Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with chronic lymphocytic leukemia Meeting Abstract


Authors: Flinn, I.; Patel, M.; Kahl, B. S.; Horwitz, S. M.; Foss, F. M.; Oki, Y.; Porcu, P.; Sweeney, J.; Allen, K.; Faia, K.; Harris, P.; Dunbar, J.; Stern, H. M.; Kelly, P.; O'Brien, S.
Abstract Title: Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with chronic lymphocytic leukemia
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385001264
PROVIDER: wos
DOI: 10.1182/blood.V122.21.677.677
Notes: Meeting Abstract: 677 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz